Abstract
Pain is a common and highly distressing symptom in pediatric patients with advanced malignancies. Prompt recognition, assessment, and treatment of pain are necessary, especially at the end of life. Opioid medications remain the mainstay of treatment of malignant pain in children at the end of life and the amount of opioids required for adequate pain control in patients is highly variable. Nonpharmacological approaches including behavioral and physical approaches in addition to non-opioid pain medications should be used when possible to augment pain control. Identification and treatment of any underlying pathology is important and use of adjuvant medications based on pathophysiology and source of pain should be considered. In cases where adequate pain control is not achieved through these multiple modalities, an interdisciplinary approach including potential interventional techniques and alternative treatments is required. This multimodal approach to pain management is best provided by interdisciplinary teams, as these teams can best address the complex causes of pain and associated distress that occurs in patients and within families.
Similar content being viewed by others
References
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342(5):326–33. doi:10.1056/NEJM200002033420506.
Drake R, Frost J, Collins JJ. The symptoms of dying children. J Pain Symptom Manag. 2003;26(1):594–603.
Goldman A, Hewitt M, Collins GS, Childs M, Hain R. Symptoms in children/young people with progressive malignant disease: United Kingdom Children’s Cancer Study Group/Paediatric Oncology Nurses Forum survey. Pediatrics. 2006;117(6):e1179–86. doi:10.1542/peds.2005-0683.
Wolfe J, Orellana L, Ullrich C, Cook EF, Kang TI, Rosenberg A, et al. Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST Study. J Clin Oncol. 2015;33(17):1928–35. doi:10.1200/JCO.2014.59.1222.
Contro NA, Larson J, Scofield S, Sourkes B, Cohen HJ. Hospital staff and family perspectives regarding quality of pediatric palliative care. Pediatrics. 2004;114(5):1248–52. doi:10.1542/peds.2003-0857-L.
Kreicbergs U, Valdimarsdottir U, Onelov E, Bjork O, Steineck G, Henter JI. Care-related distress: a nationwide study of parents who lost their child to cancer. J Clin Oncol. 2005;23(36):9162–71. doi:10.1200/JCO.2005.08.557.
Klick JC, Hauer J. Pediatric palliative care. Curr Probl Pediatr Adolesc Health Care. 2010;40(6):120–51. doi:10.1016/j.cppeds.2010.05.001.
Cohen LL, Lemanek K, Blount RL, Dahlquist LM, Lim CS, Palermo TM et al. Evidence-based assessment of pediatric pain. J Pediatr Psychol. 2008;33(9):939–55. doi:10.1093/jpepsy/jsm103 (discussion 56–7).
Palermo TM, Chambers CT. Parent and family factors in pediatric chronic pain and disability: an integrative approach. Pain. 2005;119(1–3):1–4. doi:10.1016/j.pain.2005.10.027.
Friedrichsdorf SJ, Kang TI. The management of pain in children with life-limiting illnesses. Pediatr Clin N Am. 2007;54(5):645–72, x. doi:10.1016/j.pcl.2007.07.007.
American Academy of Pediatrics Council on Children with Disabilities. Care coordination in the medical home: integrating health and related systems of care for children with special health care needs. Pediatrics. 2005;116(5):1238–44. doi:10.1542/peds.2005-2070.
Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65–76.
Dussel V, Kreicbergs U, Hilden JM, Watterson J, Moore C, Turner BG, et al. Looking beyond where children die: determinants and effects of planning a child’s location of death. J Pain Symptom Manag. 2009;37(1):33–43. doi:10.1016/j.jpainsymman.2007.12.017.
Anderson-Estill M, Neary J. Epidural and intrathecal analgesia in a rural setting. AANA J. 1993;61(1):73–80.
Mercadante S, Agnello A, Armata MG, Pumo S. The inappropriate use of the epidural route in cancer pain. J Pain Symptom Manag. 1997;13(4):233–7.
Vickers J, Thompson A, Collins GS, Childs M, Hain R. Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group. J Clin Oncol. 2007;25(28):4472–6. doi:10.1200/JCO.2007.12.0493.
Anghelescu DL, Faughnan LG, Baker JN, Yang J, Kane JR. Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service. Paediatr Anaesth. 2010;20(12):1070–7. doi:10.1111/j.1460-9592.2010.03449.x.
Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152(1):14–27. doi:10.1016/j.pain.2010.07.031.
Ingelmo PM, Fumagalli R. Neuropathic pain in children. Minerva anestesiologica. 2004;70(5):393–8.
Scadding JW. Treatment of neuropathic pain: historical aspects. Pain Med. 2004;5(Suppl 1):S3–8.
WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2012. http://apps.who.int/iris/bitstream/10665/44540/1/9789241548120_Guidelines.pdf.
Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol. 2000;40(2):124–32.
Levesque LE, Brophy JM, Zhang B. The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med. 2005;142(7):481–9.
McGrath PJ, Stevens BJ, Walker SM, Zempsky WT. Oxford textbook of paediatric pain. Oxford: Oxford University Press; 2014.
Turk DC, Swanson KS, Tunks ER. Psychological approaches in the treatment of chronic pain patients—when pills, scalpels, and needles are not enough. Can J Psychiatry. 2008;53(4):213–23.
Sage N, Sowden M, Chorlton E, Edeleanu A. CBT for chronic illness and palliative care: a workbook and toolkit. New Jersey: Wiley; 2008.
Logan DR, Coakley RM, Barber Garcia BN. Cognitive-behavioural interventions. In: McGrath PJ, Stevens BJ, Walker SM, Zempsky WT, editors. Oxford textbook of paediatric pain. Oxford: Oxford University Press; 2014. p. 519–30.
Palermo T, editor. Cognitive behavioral therapy for chronic pain. Oxford: Oxford University Press; 2012.
Campos RG. Rocking and pacifiers: two comforting interventions for heelstick pain. Res Nurs Health. 1994;17(5):321–31.
Cohen LL, Bernard RS, Greco LA, McClellan CB. A child-focused intervention for coping with procedural pain: are parent and nurse coaches necessary? J Psychol. 2002;27(8):749–57.
Ybarra GJ, Passman RH, Eisenberg CS. The presence of security blankets or mothers (or both) affects distress during pediatric examinations. J Consult Clin Psychol. 2000;68(2):322–30.
Otis J. Managing chronic pain: a cognitive-behavioral therapy approach—therapist guide. New York: Oxford University Press; 2007.
Stevens B, Taddio A, Ohlsson A, Einarson T. The efficacy of sucrose for relieving procedural pain in neonates–a systematic review and meta-analysis. Acta Paediatr. 1997;86(8):837–42.
Tupper SM, Swiggum MS, O'Rourke D, Sangster ML. Physical therapy interventions for pain in childhood and adolescence. In: McGrath PJ, Stevens BJ, Walker SM, Zempsky WT, editors. Oxford textbook of paediatric pain. Oxford: Oxford University Press; 2014. p. 581–9.
Holsti L, Backman CL, Engel JM. Occupational therapy. In: McGrath PJ, Stevens BJ, Walker SM, Zempsky WT, editors. Oxford textbook of paediatric pain. Oxford: Oxford University Press; 2014. p. 590–9.
Zernikow B, Michel E, Craig F, Anderson BJ. Pediatric palliative care: use of opioids for the management of pain. Paediatr Drugs. 2009;11(2):129–51. doi:10.2165/00148581-200911020-00004.
Collins JJ, Berde BC, Grier HE, Nachmanoff DB, Kinney HC. Massive opioid resistance in an infant with localized metastasis to the midbrain periaqueductal gray. Pain. 1995;63(2):271–5.
Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in children with terminal malignancy. J Pediatr. 1995;126(4):653–7.
Miser AW, Miser JS, Clark BS. Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr. 1980;96(5):930–2.
Miser AW, Davis DM, Hughes CS, Muine AF, Miser JS. Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child. 1983;137(4):383–5.
Sirkia K, Hovi L, Pouttu J, Saarinen-Pihkala UM. Pain medication during terminal care of children with cancer. J Pain Symptom Manag. 1998;15(4):220–6.
Hewitt M, Goldman A, Collins GS, Childs M, Hain R. Opioid use in palliative care of children and young people with cancer. J Pediatr. 2008;152(1):39–44. doi:10.1016/j.jpeds.2007.07.005.
Siden H, Nalewajek. High dose opioids in pediatric palliative care. J Pain Symptom Manag. 2003;25(5):397–9.
Berde CB, Lehn BM, Yee JD, Sethna NF, Russo D. Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr. 1991;118(3):460–6.
Nelson KL, Yaster M, Kost-Byerly S, Monitto CL. A national survey of American Pediatric Anesthesiologists: patient-controlled analgesia and other intravenous opioid therapies in pediatric acute pain management. Anesth Analg. 2010;110(3):754–60. doi:10.1213/ANE.0b013e3181ca749c.
Howard RF, Lloyd-Thomas A, Thomas M, Williams DG, Saul R, Bruce E, et al. Nurse-controlled analgesia (NCA) following major surgery in 10,000 patients in a children’s hospital. Paediatr Anaesth. 2010;20(2):126–34. doi:10.1111/j.1460-9592.2009.03242.x.
Anghelescu DL, Burgoyne LL, Oakes LL, Wallace DA. The safety of patient-controlled analgesia by proxy in pediatric oncology patients. Anesth Analg. 2005;101(6):1623–7. doi:10.1213/01.ANE.0000184198.13285.33.
Anghelescu DL, Faughnan LG, Oakes LL, Windsor KB, Pei D, Burgoyne LL. Parent-controlled PCA for pain management in pediatric oncology: is it safe? J Pediatr Hematol Oncol. 2012;34(6):416–20. doi:10.1097/MPH.0b013e3182580496.
Anghelescu DL, Zhang K, Faughnan LG, Pei D. The safety and effectiveness of patient-controlled analgesia in outpatient children and young adults with cancer: a retrospective study. J Pediatr Hematol Oncol. 2015;37(5):378–82. doi:10.1097/MPH.0000000000000354.
Schiessl C, Gravou C, Zernikow B, Sittl R, Griessinger N. Use of patient-controlled analgesia for pain control in dying children. Support Care Cancer. 2008;16(5):531–6. doi:10.1007/s00520-008-0408-2.
Anghelescu DL, Snaman JM, Trujillo L, Sykes AD, Yuan Y, Baker JN. Patient-controlled analgesia at the end of life at a pediatric oncology institution. Pediatr Blood Cancer. 2015;62(7):1237–44. doi:10.1002/pbc.25493.
Hunt A, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr. 1999;135(1):47–55.
Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother. 2002;16(4):5–18.
Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol. 2000;27(7):524–8.
Anghelescu DL, Faughnan LG, Hankins GM, Ward DA, Oakes LL. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag. 2011;7(5):353–61.
Maxwell LG, Kaufmann SC, Bitzer S, Jackson EV Jr, McGready J, Kost-Byerly S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg. 2005;100(4):953–8. doi:10.1213/01.ANE.0000148618.17736.3C.
Flerlage JE, Baker JN. Methylnaltrexone for opioid-induced constipation in children and adolescents and young adults with progressive incurable cancer at the end of life. J Palliat Med. 2015;18(7):631–3. doi:10.1089/jpm.2014.0364.
Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol. 2009;7(1):39–46.
Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, et al. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manag. 2009;38(5):683–90. doi:10.1016/j.jpainsymman.2009.02.234.
Moryl N, Coyle N, Foley KM. Managing an acute pain crisis in a patient with advanced cancer: “this is as much of a crisis as a code”. Jama. 2008;299(12):1457–67. doi:10.1001/jama.299.12.1457.
Leung JG, Nelson S, Leloux M. Pharmacotherapy during the end of life: caring for the actively dying patient. AACN Adv Crit Care. 2014;25(2):79–88. doi:10.1097/NCI.0000000000000010 (quiz 9–90).
McPherson ML, Kim M, Walker KA. 50 practical medication tips at end of life. J Support Oncol. 2012;10(6):222–9. doi:10.1016/j.suponc.2012.08.002.
Zeppetella G. Evidence-based treatment of cancer-related breakthrough pain with opioids. J Natl Compr Canc Netw JNCCN. 2013;11(Suppl 1):S37–43.
Harlos MS, Stenekes S, Lambert D, Hohl C, Chochinov HM. Intranasal fentanyl in the palliative care of newborns and infants. J Pain Symptom Manag. 2013;46(2):265–74. doi:10.1016/j.jpainsymman.2012.07.009.
. In: Schechter N, Berde, CB, Yaster, M., editor. Pain in Infants, Children, and Adolescents. 2nd ed.: Lippincott Williams & Wilkins. p. 850.
Smith HS, Peppin JF. Toward a systematic approach to opioid rotation. J Pain Res. 2014;7:589–608. doi:10.2147/JPR.S55782.
Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012;153(2):359–65. doi:10.1016/j.pain.2011.10.028.
Berde C, Wolfe J. Pain, anxiety, distress, and suffering: interrelated, but not interchangeable. J Pediatr. 2003;142(4):361–3. doi:10.1067/mpd.2003.194.
Strasser F, Walker P, Bruera E. Palliative pain management: when both pain and suffering hurt. J Palliat Care. 2005;21(2):69–79.
Jackson K, Ashby M, Howell D, Petersen J, Brumley D, Good P, et al. The effectiveness and adverse effects profile of “burst” ketamine in refractory cancer pain: The VCOG PM 1-00 study. J Palliat Care. 2010;26(3):176–83.
Toombs JD, Kral LA. Methadone treatment for pain states. Am Fam Physician. 2005;71(7):1353–8.
McGraw T, Stacey BR. Gabapentin for treatment of neuropathic pain in a 12-year-old girl. Clin J Pain. 1998;14(4):354–6.
Gay CT. An 8-year-old girl with unilateral facial and ear pain and isolated frontal headaches. Semin Pediatr Neurol. 1999;6(3):182–8 (discussion 9).
Keskinbora K, Pekel AF, Aydinli I. The use of gabapentin in a 12-year-old boy with cancer pain. Acta Anaesthesiol Scand. 2004;48(5):663–4. doi:10.1111/j.0001-5172.2004.0376c.x.
Rusy LM, Troshynski TJ, Weisman SJ. Gabapentin in phantom limb pain management in children and young adults: report of seven cases. J Pain Symptom Manag. 2001;21(1):78–82.
Butkovic D, Toljan S, Mihovilovic-Novak B. Experience with gabapentin for neuropathic pain in adolescents: report of five cases. Paediatr Anaesth. 2006;16(3):325–9. doi:10.1111/j.1460-9592.2005.01687.x.
Guay DR. Pregabalin in neuropathic pain: a more “pharmaceutically elegant” gabapentin? Am J Geriatr Pharmacother. 2005;3(4):274–87.
Vondracek P, Oslejskova H, Kepak T, Mazanek P, Sterba J, Rysava M, et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol. 2009;13(4):332–6. doi:10.1016/j.ejpn.2008.06.011.
McNicol E, Strassels S, Goudas L, Lau J, Carr D. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol. 2004;22(10):1975–92. doi:10.1200/JCO.2004.10.524.
Mercadante S, Fulfaro F, Casuccio A. A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer. 2002;38(10):1358–63.
Mercadante S, Casuccio A, Agnello A, Pumo S, Kargar J, Garofalo S. Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms. J Pain Symptom Manag. 1999;17(5):351–6.
Paulsen O, Aass N, Kaasa S, Dale O. Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manag. 2013;46(1):96–105. doi:10.1016/j.jpainsymman.2012.06.019.
Bonabello A, Galmozzi MR, Bruzzese T, Zara GP. Analgesic effect of bisphosphonates in mice. Pain. 2001;91(3):269–75.
Hatoum HT, Lin SJ, Smith MR, Barghout V, Lipton A. Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database. Cancer. 2008;113(6):1438–45. doi:10.1002/cncr.23775.
Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 2001;91(7):1191–200.
Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94(19):1458–68.
August KJ, Dalton A, Katzenstein HM, George B, Olson TA, Wasilewski-Masker K, et al. The use of zoledronic acid in pediatric cancer patients. Pediatr Blood Cancer. 2011;56(4):610–4. doi:10.1002/pbc.22681.
Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25(11):1423–36. doi:10.1200/JCO.2006.09.5281.
Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. 2014;15(2):164–71. doi:10.1016/S1470-2045(13)70556-4.
Hewitt M, Goldman A, Collins GS, Childs M, Hain R. Opioid use in palliative care of children and young people with cancer. J Pediatr. 2008;152(1):39–44.
Baker JN, Anghelescu DL, Kane JR. Pain still lords over children. J Pediatr. 2008;152(1):6–8. doi:10.1016/j.jpeds.2007.08.019.
Rork JF, Berde CB, Goldstein RD. Regional anesthesia approaches to pain management in pediatric palliative care: a review of current knowledge. J Pain Symptom Manag. 2013;46(6):859–73. doi:10.1016/j.jpainsymman.2013.01.004.
Galloway K, Staats PS, Bowers DC. Intrathecal analgesia for children with cancer via implanted infusion pumps. Med Pediatr Oncol. 2000;34(4):265–7.
Patt RB, Payne R, Farhat GA, Reddy SK. Subarachnoid neurolytic block under general anesthesia in a 3-year-old with neuroblastoma. Clin J Pain. 1995;11(2):143–6.
Berde CB, Sethna NF, Fisher DE, Kahn CH, Chandler P, Grier HE. Celiac plexus blockade for a 3-year-old boy with hepatoblastoma and refractory pain. Pediatrics. 1990;86(5):779–81.
Staats PS, Kost-Byerly S. Celiac plexus blockade in a 7-year-old child with neuroblastoma. J Pain Symptom Manag. 1995;10(4):321–4. doi:10.1016/0885-3924(95)00014-P.
Baker L, Lee M, Regnard C, Crack L, Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med. 2004;18(6):507–15.
Coyne PJ, Smith T, Laird J, Hansen LA, Drake D. Effectively starting and titrating intrathecal analgesic therapy in patients with refractory cancer pain. Clin J Oncol Nurs. 2005;9(5):581–3. doi:10.1188/05.CJON.581-583.
Chambers WA. Nerve blocks in palliative care. Br J Anaesth. 2008;101(1):95–100. doi:10.1093/bja/aen105.
Collins JJ, Grier HE, Sethna NF, Wilder RT, Berde CB. Regional anesthesia for pain associated with terminal pediatric malignancy. Pain. 1996;65(1):63–9.
Berde CB, Fischel N, Filardi JP, Coe CS, Grier HE, Bernstein SC. Caudal epidural morphine analgesia for an infant with advanced neuroblastoma: report of a case. Pain. 1989;36(2):219–23.
Aram L, Krane EJ, Kozloski LJ, Yaster M. Tunneled epidural catheters for prolonged analgesia in pediatric patients. Anesth Analg. 2001;92(6):1432–8.
Plancarte R, Patt R. Intractable upper body pain in a pediatric patient relieved with cervical epidural opioid administration. J Pain Symptom Manag. 1991;6(2):98–9.
Portas M, Marty JY, Buttin C, Gentet JC, Coze C, Fallouh K, et al. Refractory pain in children with cancer: role of peridural analgesia. Arch Pediatr. 1998;5(8):851–60.
Queinnec MC, Esteve M, Vedrenne J. Positive effect of regional analgesia (RA) in terminal stage paediatric chondrosarcoma: a case report and the review of the literature. Pain. 1999;83(2):383–5.
Berde CB, Sethna NF, Conrad LS, Hershenson MB, Shillito J Jr. Subarachnoid bupivacaine analgesia for seven months for a patient with a spinal cord tumor. Anesthesiology. 1990;72(6):1094–6.
Meignier M, Ganansia MF, Lejus C, Testa S. Intrathecal morphine therapy in children with cancer. Cah Anesthesiol. 1992;40(7):487–90.
Tobias JD. Applications of intrathecal catheters in children. Paediatr Anaesth. 2000;10(4):367–75.
Cooper MG, Keneally JP, Kinchington D. Continuous brachial plexus neural blockade in a child with intractable cancer pain. J Pain Symptom Manag. 1994;9(4):277–81.
Aspinall RL, Mayor A. A prospective randomized controlled study of the efficacy of ketamine for postoperative pain relief in children after adenotonsillectomy. Paediatr Anaesth. 2001;11(3):333–6.
Finkel JC, Pestieau SR, Quezado ZM. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain. 2007;8(6):515–21. doi:10.1016/j.jpain.2007.02.429.
Klepstad P, Borchgrevink P, Hval B, Flaat S, Kaasa S. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol. 2001;23(9):616–9.
Tsui BC, Davies D, Desai S, Malherbe S. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol. 2004;26(10):678–80.
Greco C, Berde C. Pain management for the hospitalized pediatric patient. Pediatr Clin N Am. 2005;52(4):995–1027, vii–viii. doi:10.1016/j.pcl.2005.04.005.
Anghelescu DL, Hamilton H, Faughnan LG, Johnson LM, Baker JN. Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer. J Palliat Med. 2012;15(10):1082–90. doi:10.1089/jpm.2011.0500.
Acknowledgments
We would like to thank Vani Shanker, PhD, ELS, for scientific editing of this manuscript, and members of the Child Life Program and biomedical communications groups at St. Jude Children’s Research Hospital for their support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors (Jennifer M. Snaman, Justin N. Baker, Jennifer H. Ehrentraut, and Doralina L. Anghelescu) do not have any conflicts of interest to report.
Funding
No funding was used in the preparation of this manuscript.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Snaman, J.M., Baker, J.N., Ehrentraut, J.H. et al. Pediatric Oncology: Managing Pain at the End of Life. Pediatr Drugs 18, 161–180 (2016). https://doi.org/10.1007/s40272-016-0168-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-016-0168-2